Abstract
Background In the early stages of life, anemia leads to severe negative consequences on the cognitive, growth and development of children. The Ethiopian demographic and health survey showed an increasing trend of anemia nationally.
Objective The aim of this study is to assess the magnitude and factors associated with anemia among under-five children.
Methods A health facility based cross sectional study was conducted among 409 systematically selected children 6-59 months attending services at public and private health institutions in Kombolcha Town, Northeast Ethiopia. Data were collected using structured questioner from mother or caretakers. The data entry and analysis were done by SPSS version 20. Binary logistic regression was fitted to determine associations. The odds ratio with the 95% confidence intervals were reported.
Results From the total participant 213(53.9%) were males with the mean age of 26 months (SD+15.2). The overall prevalence of anemia was 52.2% (95% CI, 46.8%-57%). Being in the age of 6-11 months (AOR= 6.23, 95% CI: 2.44, 15.95), 12-23 months (AOR= 3.74, 95%CI: 1.63, 8.60), maternal age ≥30 years (AOR=0.37 (0.18, 0.77), exclusive breast feeding until six months (AOR=0.27, 95% CI: 0.16, 0.45), having low dietary diversity score (AOR=2.61, 95% CI: 1.55, 4.38), having history of diarrhea (AOR= 1.87, 95% CI: 1.12, 3.12) and having the lowest family monthly income (AOR=16.97, 95% CI: 4.95, 58.20) were identified as factors associated with anemia.
Conclusion The magnitude of anemia in children was a public health problem in the study area. child age, maternal age, exclusive breastfeeding, dietary diversity score, diarrhea and family income were found to be associated with anemia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by a Research and Ethics Committee of College of medicine and health sciences, Wollo University with approval number "CMHS1178/13/12".
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.